Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

OptiPranolol

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2003
Review
2003
PURPOSE To determine the calculated daily patient cost (cost minimization) of medical glaucoma therapy and review cost trends… Expand
Is this relevant?
Review
2001
Review
2001
PurposeWith the recent addition of several new ocular hypotensive agents to the pharmacopeia, glaucomatologists have more choices… Expand
Is this relevant?
Highly Cited
1999
Highly Cited
1999
PURPOSE To determine the calculated daily patient cost (cost minimization) of medical glaucoma therapy. METHODS The actual… Expand
Is this relevant?
1997
1997
Objective: To evaluate the daily cost of β-blocker therapy among commercially available products. Methods: Ten different… Expand
Is this relevant?
1997
1997
OBJECTIVE To evaluate the daily cost of beta-blocker therapy among commercially available products. METHODS Ten different beta… Expand
Is this relevant?
1994
1994
  • C. KeBler
  • Archives of ophthalmology
  • 1994
  • Corpus ID: 2627332
In the December 1993 issue of theArchives, a case report about possible uveitis secondary to metipranolol (OptiPranolol) therapy… Expand
Is this relevant?
1993
1993
Metipranolol hydrochloride is a topical β blocker used in the treatment of glaucoma. It has been in widespread use throughout… Expand
Is this relevant?
1992
1992
• We compared the cost per drop and cost per year of therapy for five commercially available ocular β-blockers (Timoptic, Betagan… Expand
Is this relevant?
1992
1992
We compared the cost per drop and cost per year of therapy for five commercially available ocular beta-blockers (Timoptic… Expand
Is this relevant?